{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:26:33Z","timestamp":1780100793500,"version":"3.54.0"},"reference-count":57,"publisher":"Institute of Biochemistry","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BIOMED KHIM"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Comparative mass spectrometry analysis of hippocampal tissue samples from patients with sclerotic and non-sclerotic temporal lobe epilepsy and nonepileptic patients was undertaken to identify differences in the levels of protein post-translational modifications (PTMs). The original proteomic data obtained by Mathoux et al. [DOI: 10.1172\/jci.insight.188612] and deposited in the PRIDE repository (PXD064519) were used in this work. Our reanalysis of the comparative proteomic data identified 53 proteins with PTMs (phosphorylation, methylation, acetylation, and citrullination) that exhibited significant changes in the levels of individual modified peptides. According to the published original data, all 53 proteins are involved in processes associated with neurological diseases in general and epileptogenesis in particular. The analysis identified PTMs of proteins that could play an important role in the pathogenesis of neurological diseases.<\/jats:p>","DOI":"10.18097\/pbmcr1612","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:40:22Z","timestamp":1762422022000},"page":"351-363","source":"Crossref","is-referenced-by-count":1,"title":["Identification of proteins with variable levels of post-translational modifications in human temporal lobe epilepsy"],"prefix":"10.18097","volume":"71","author":[{"given":"Yu.V.","family":"Miroshnichenko","sequence":"first","affiliation":[{"name":"Institute of Biomedical Chemistry, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Rybina","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.S.","family":"Skvortsov","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7443","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Skvortsov V.S., Ivanova Ya.O., Voronina A.I. (2021) The bioinformatic identification of proteins with varying levels of post-translational modifications in experimental ischemic stroke in mice. Biomeditsinskaya Khimiya, 67(6), 475\u2013484.","DOI":"10.18097\/PBMC20216706475"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Voronina A.I., Miroshnichenko Yu.V., Skvortsov V.S. (2024) Bioinformatic identification of proteins with altered PTM levels in a mouse line established to study the mechanisms of the development of fibromuscular dysplasia. Biomeditsinskaya Khimiya, 70(4), 248\u2013255.","DOI":"10.18097\/PBMC20247004248"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Martens L., Hermjakob H., Jones P., Adamski M., Taylor C., States D., Gevaert K., Vandekerckhove J., Apweiler R. (2005) PRIDE: the proteomics identifications database. Proteomics, 5(13), 3537\u20133545.","DOI":"10.1002\/pmic.200401303"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Salovska B., Liu Y. (2023) Post-translational modification and phenotype. Proteomics, 23(3\u20134), e2200535.","DOI":"10.1002\/pmic.202200535"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Yamaguchi K., Hu Y.-Y., Kawajiri K., Itakura M., Nakashima F., Shibata T., Uchida K. (2025) Adductome-based identification of lysine monomethylation as a key post-translational protein modification in autoimmune diseases. J. Biol. Chem., 301(10), 110684.","DOI":"10.1016\/j.jbc.2025.110684"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Tuli L., Tsai T.-H., Varghese R.S., Xiao J.F., Cheema A., Ressom H.W. (2012) Using a spike-in experiment to evaluate analysis of LC-MS data . Proteome Sci., 10, 13.","DOI":"10.1186\/1477-5956-10-13"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Ramazi S., Zahiri J. (2021) Posttranslational modifications in proteins: resources, tools and prediction methods. Database (Oxford), 2021, baab012.","DOI":"10.1093\/database\/baab012"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Mathoux J., Wilson M.M., Srinivas S., Litovskich G., Villalba B.L., Tran C., Kesavan J., Harnett A., Auer T., Sanz-Rodriguez A., Alkhayyat M.Kh.A.E., Sullivan M., Liu Z., Huang Y., Lacey A., Delanty N., Cryan J., Brett F.M., Farrell M.A., O'Brien D.F., Casillas-Espinosa P.M., Jimenez-Mateos E.M., Glennon J.C., Canavan M., Henshall D.C., Brennan G.P. (2025) N6-methyladenosine (m6A) dysregulation contributes to network excitability in temporal lobe epilepsy. JCI Insight, 10(14), e188612.","DOI":"10.1172\/jci.insight.188612"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Chen Y., Nie Q., Song T., Zou X., Li Q., Zhang P. (2025) Integrated proteomics and lipidomics analysis of hippocampus to reveal the metabolic landscape of epilepsy. ACS Omega, 10(9), 9351\u20139367.","DOI":"10.1021\/acsomega.4c10085"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Ma B., Zhang K., Hendrie C., Liang C., Li M., Doherty-Kirby A., Lajoie G. (2003) PEAKS: Powerful software for peptide de novo sequencing by tandem mass spectrometry. Rapid Commun. Mass Spectrom., 17(20), 2337\u20132342.","DOI":"10.1002\/rcm.1196"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"The UniProt Consortium (2020) UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res., 49(D1), D480\u2013D489.","DOI":"10.1093\/nar\/gkaa1100"},{"key":"ref12","unstructured":"Progenesis LC-MS version 4.0, Nonlinear Dynamics, Newcastle upon Tyne, UK."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Skvortsov V.S., Alekseychuk N.N., Miroshnichenko Yu.V., Rybina A.V. (2019) The prediction of the ion fraction of the peptide with selected charge in mass spectrometry with positive electrospray ionization. Biomedical Chemistry: Research and Methods, 2(4), e00100.","DOI":"10.18097\/BMCRM00100"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Balmik A.A., Chinnathambi S. (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease. Cell Commun. Signal., 19, 51.","DOI":"10.1186\/s12964-021-00732-z"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Park J.-Y., Kang T.-C. (2018) The differential roles of PEA15 phosphorylations in reactive astrogliosis and astroglial apoptosis following status epilepticus. Neurosci. Res., 137, 11\u201322.","DOI":"10.1016\/j.neures.2018.02.003"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chang Q., Yang H., Wang M., Wei H., Hu F. (2018) Role of microtubule-associated protein in autism spectrum disorder. Neurosci. Bull., 34(6), 1119\u20131126.","DOI":"10.1007\/s12264-018-0246-2"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Sanchez C., D\u00edaz-Nido J., Avila J. (2000) Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog. Neurobiol., 61(2), 133\u2013168.","DOI":"10.1016\/s0301-0082(99)00046-5"},{"key":"ref18","unstructured":"Fritz D.I., Ding Y., Merrill-Skoloff G., Flaumenhaft R., Hanada T., Chishti A.H. (2023) Dematin regulates calcium mobilization, thrombosis, and early Akt activation in platelets. Mol. Cell. Biol., 43(6), 283\u2013299."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Li H., Fan S., Gong Z., Chan J.Y.K., Tong M.C.F., Chen G.G. (2024) Role of hematological and neurological expressed 1 (HN1) in human cancers. Crit. Rev. Oncol. Hematol., 201, 104446.","DOI":"10.1016\/j.critrevonc.2024.104446"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Xin Y., Lin G., Hua T., Liang J., Sun T., Wu X. (2023) The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy. Open Life Sci., 18, 20220595.","DOI":"10.1515\/biol-2022-0595"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhang L., Feng D., Tao H., De X., Chang Q., Hu Q. (2015) Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomed. Rep., 3(1), 28\u201332.","DOI":"10.3892\/br.2014.386"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Gozal Y.M., Seyfried N.T., Gearing M., Glass J.D., Heilman C.J., Wuu J., Duong D.M., Cheng D., Xia Q., Rees H.D., Fritz J.J., Cooper D.S., Peng J., Levey A.I., Lah J.J. (2011) Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration. Mol. Neurodegener., 6, 82.","DOI":"10.1186\/1750-1326-6-82"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Thal D., Xavier C.-P., Rosentreter A., Linder S., Friedrichs B., Waha A., Pietsch T., Stumpf M., Noegel A., Clemen C. (2008) Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J. Pathol., 214(4), 415\u2013424.","DOI":"10.1002\/path.2308"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Kong Q., Min X., Sun R., Gao J., Liang R., Li L., Chu X. (2016) Effects of pharmacological treatments on hippocampal NCAM1 and ERK2 expression in epileptic rats with cognitive dysfunction. Oncol. Lett., 12(3), 1783\u20131791.","DOI":"10.3892\/ol.2016.4882"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Nicolay N.H., Hertle D., Boehmerle W., Heidrich F.M., Yeckel M., Ehrlich B.E. (2007) Inositol 1,4,5 trisphosphate receptor and chromogranin B are concentrated in different regions of the hippocampus. J. Neurosci. Res., 85(9), 2026\u20132036.","DOI":"10.1002\/jnr.21328"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Franchi F. Marte A., Corradi B., Sterlini B., Alberini G., Romei A., de Fusco A., Vogel A., Maragliano L., Baldelli P., Corradi A., Valente P., Benfenati F. (2023) The intramembrane COOH-terminal domain of PRRT2 regulates voltagedependent Na+ channels. J. Biol. Chem., 299(5), 104632.","DOI":"10.1016\/j.jbc.2023.104632"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Barzasi M., Spinola A., Costa A., Pavinato L., Brusco A., Marcello E., DiLuca M., Gardoni F. (2025) Arg209Lys and Gln508His missense variants in Rabphilin 3A cause pre- and post-synaptic dysfunctions at excitatory glutamatergic synapses. Sci. Rep., 15, 8698.","DOI":"10.1038\/s41598-025-93403-9"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zhu J.X., Aswad D.W. (2024) Isoaspartate formation and irreversible aggregation of collapsin response mediator protein 2: implications for the etiology of epilepsy and age-related cognitive decline. Amino Acids, 57, 5.","DOI":"10.1007\/s00726-024-03435-0"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Cantor J.R., Stone E.M., Chantranupong L., Georgiou G. (2009) The human asparaginase-like protein 1 hASRGL1 is an Ntn hydrolase with beta-aspartyl peptidase activity. Biochemistry, 48(46), 11026\u201311031.","DOI":"10.1021\/bi901397h"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Werren E.A., Rodriguez Bey G., Majethia P., Kaur P., Patil S.J., Kekatpure M.V., Afenjar A., Qebibo L., Burglen L., Tomoum H., Demurger F., Duborg C., Siddiqui S., Tsan Y.-C., Abdullah U., Ali Z., Saadi S.M., Baig S.M., Houlden H., Maroofian R., Padiath Q.S., Bielas S.L., Shukla A. (2024) Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects. Brain, 147(12), 4033\u20134042.","DOI":"10.1093\/brain\/awae299"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Olah J., Bertrand P., Ovadi J. (2017) Role of the microtubuleassociated TPPP\/p25 in Parkinson's and related diseases and its therapeutic potential. Expert Rev. Proteomics, 14(4), 301\u2013309.","DOI":"10.1080\/14789450.2017.1304216"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Liu X.-Y., Yang J.-L., Chen L.-J., Zhang Y., Yang M.-L., Wu Y.-Y., Li F.-Q., Tang M.-H., Liang S.-F., Wei Y.-Q. (2008) Comparative proteomics and correlated signaling networkof rat hippocampus in the pilocarpine model of temporal lobe epilepsy. Proteomics, 8(3), 582\u2013603.","DOI":"10.1002\/pmic.200700514"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Singhal A., Morris V.B., Labhasetwar V., Ghorpade A. (2013) Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis., 4(11), e903.","DOI":"10.1038\/cddis.2013.362"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Guimar\u00e3es T.G., Parmera J.B., Castro M.A.A., Cury R.G., Barbosa E.R., Kok F. (2024) X-Linked levodopa-responsive parkinsonism-epilepsy syndrome: a novel PGK1 mutation and literature review. Mov. Disord. Clin. Pract., 11(5), 556\u2013566.","DOI":"10.1002\/mdc3.13992"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Nielsen V.G., Jacobsen W.K. (2016) Iron modulates the alpha chain of fibrinogen. Biometals, 29(2), 235\u2013238.","DOI":"10.1007\/s10534-016-9909-5"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-R J. (1992) Na+\/K(+)-ATPase regulation by neurotransmitters. Neurochem. Int., 20(1), 1\u201310.","DOI":"10.1016\/0197-0186(92)90119-c"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Olrichs N.K., Mahalka A.K., Kaloyanova D., Kinnunen P.K., Bernd H.J. (2014) Golgi-associated plant pathogenesis related protein 1 (GAPR-1) forms amyloid-like fibrils by interaction with acidic phospholipids and inhibits a aggregation. Amyloid, 21(2), 88\u201396.","DOI":"10.3109\/13506129.2014.882304"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Nakashima S. (2002) Protein kinase C alpha (PKC alpha): regulation and biological function. J. Biochem., 132(5), 669\u2013675.","DOI":"10.1093\/oxfordjournals.jbchem.a003272"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Petersen S.L., Intlekofer K.A., Moura-Conlon P.J., Brewer D.N., del Pino Sans J., Lopez J.A. (2013) Novel progesterone receptors: neural localization and possible functions. Front. Neurosci., 7, 164.","DOI":"10.3389\/fnins.2013.00164"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Fedotcheva T.A., Shimanovsky N.L. (2025) Neurosteroids progesterone and dehydroepiandrosterone: molecular mechanisms of action in neuroprotection and neuroinflammation. Pharmaceuticals (Basel), 18(7), 945.","DOI":"10.3390\/ph18070945"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Huang Z., Shen S., Han X., Li W., Luo W., Lin L., Xu M., Wang Y., Huang W., Wu G., Liang G. (2023) Macrophage DCLK1 promotes atherosclerosis via binding to IKK\u03b2 and inducing inflammatory responses. EMBO Mol. Med., 15(5), e17198.","DOI":"10.15252\/emmm.202217198"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Mastroeni D., Sekar S., Nolz J., Delvaux E., Lunnon K., Mill J., Liang W.S., Coleman P.D. (2017) ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity. PLOS One, 12(7), e0177814.","DOI":"10.1371\/journal.pone.0177814"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Wang X., Chen G., Wan B., Dong Z., Xue Y., Luo Q., Wang D., Lu Y., Zhu L. (2022) NRF1-mediated microglial activation triggers high-altitude cerebral edema. J. Mol. Cell Biol., 14(5), mjac036.","DOI":"10.1093\/jmcb\/mjac036"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Blondiaux A., Jia S., Annamneedi A., \u00c7al\u0131\u015fkan G., Nebel J., Montenegro-Venegas C., Wykes R.C., Fejtova A., Walker M.C., Stork O., Gundelfinger E.D., Dityatev A., Seidenbecher C.I. (2023) Linking epileptic phenotypes and neural extracellular matrix remodeling signatures in mouse models of epilepsy. Neurobiol. Dis., 188, 106324.","DOI":"10.1016\/j.nbd.2023.106324"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Sun Z.M., Chen Q., Li M.H., Ma W.N., Zhao X.Y., Huang Z. (2019) Chronic phosphoproteomic in temporal lobe epilepsy mouse models induced by kainic acid. Beijing Da Xue Xue Bao Yi Xue Ban, 51(2), 197\u2013205.","DOI":"10.19723\/j.issn.1671-167X.2019.02.001"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Liu X.-B., Murray K.D. (2012) Neuronal excitability and calcium\/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia, 53(Suppl 1), 45\u201352.","DOI":"10.1111\/j.1528-1167.2012.03474.x"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Cai S., Li J., Wu Y., Jiang Y.J. (2020) De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay. Hum. Genet., 65(7), 601\u2013608.","DOI":"10.1038\/s10038-020-0739-5"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Schoonjans A.-S., Meuwissen M., Reyniers E., Kooy F., Ceulemans B. (2016) PLCB1 epileptic encephalopathies; review and expansion of the phenotypic spectrum. Eur. J. Paediatr. Neurol., 20(3), 474\u2013479.","DOI":"10.1016\/j.ejpn.2016.01.002"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Fard M.K., van der Meer F., Sanchez P., Cantuti-Castelvetri L., Mandad S., J\u00e4kel S., Fornasiero E.F., Schmitt S., Ehrlich M., Starost L., Kuhlmann T., Sergiou C., Schultz V., Wrzos C., Br\u00fcck W., Urlaub H., Dimou L., Stadelmann C., Simons M. (2017) BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci. Transl. Med., 9(419), eaam7816.","DOI":"10.1126\/scitranslmed.aam7816"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Hu S., Tang Y., Li X., Li W., Zeng Y., Jiang M., Chen R., Zheng P., Yang L., Song Z., Xie D., Chen Y., Yuan Y. (2024) Hsp90aa1\/JUN\/Ccl2 regulatory axis mediates migration and differentiation of NSPCs, promoting the onset and progression of early post-ischemic stroke epilepsy. Neurobiol. Dis., 200, 106635.","DOI":"10.1016\/j.nbd.2024.106635"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Gu C., Wang F., Zhang Y.-T., Wei S.-Z., Liu J.-Y., Sun H.-Y., Wang G.-H., Liu C.-F. (2021) Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell, 20(6), e13375.","DOI":"10.1111\/acel.13375"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Ying Z., Najm I., Nemes A., Pinheiro-Martins A.P., Alexopoulos A., Gonzalez-Martinez J., Bingaman W. (2014) Growth-associated protein 43 and progressive epilepsy in cortical dysplasia. Ann. Clin. Transl. Neurol., 1(7), 453\u2013461.","DOI":"10.1002\/acn3.69"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Xiao L., Chen W., Guo W., Li H., Chen R., Chen Q. (2025) Exploring the mechanism of action of Phyllanthus emblica in the treatment of epilepsy based on network pharmacology and molecular docking. Medicine (Baltimore), 104(7), e41414.","DOI":"10.1097\/MD.0000000000041414"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Fan B., Gu J.-Q., Yan R., Zhang H., Feng J., Ikuyama S. (2013) High glucose, insulin and free fatty acid concentrations synergistically enhance perilipin 3 expression and lipid accumulation in macrophages. Metabolism, 62(8), 1168\u20131179.","DOI":"10.1016\/j.metabol.2013.02.013"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wesseling H., Rahmoune H., Tricklebank M., Guest P.C., Bahn S. (2015) A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases\/phosphatases in rat brain. J. Proteome Res., 14(1), 411\u2013421.","DOI":"10.1021\/pr5009493"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Tavakkoli A., Abnous K., Vahdati Hassani F., Hosseinzadeh H., Birner-Gruenberger R., Mehri S. (2020) Alteration of protein profile in cerebral cortex of rats exposed to bisphenol A: a proteomics study. Neurotoxicology, 78, 1\u201310.","DOI":"10.1016\/j.neuro.2020.01.013"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Wang T., Jia L., Lv B., Liu B., Wang W., Wang F., Yang G., Bu X., Yao L., Zhang B. (2011) Human Ermin (hErmin), a new oligodendrocyte-specific cytoskeletal protein related to epileptic seizure. Brain Res., 1367, 77\u201384.","DOI":"10.1016\/j.brainres.2010.10.003"}],"container-title":["Biomeditsinskaya Khimiya"],"original-title":[],"language":"ru","deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:40:43Z","timestamp":1762422043000},"score":1,"resource":{"primary":{"URL":"http:\/\/pbmc.ibmc.msk.ru\/en\/article-en\/PBMC-2025-71-5-351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.18097\/pbmcr1612","relation":{},"ISSN":["2310-6905","2310-6972"],"issn-type":[{"value":"2310-6905","type":"electronic"},{"value":"2310-6972","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}